论文部分内容阅读
目的探讨美洛培南治疗新生儿颅内出血性脑膜炎的临床疗效。方法将90例颅内出血性脑膜炎的新生儿随机分为两组,每组45例。对照组给予头孢三嗪等常规治疗方法进行治疗,实验组在对照组基础上给予美洛培南治疗,比较两组治疗效果以及家属满意度。结果实验组总有效率91.11%,明显高于对照组的59.99%,差异有统计学意义(P<0.05)。实验组家属对治疗的满意度89.66%,明显高于对照组的62.07%,差异有统计学意义(P<0.05)。结论美洛培南治疗新生儿颅内出血性脑膜炎的临床治疗效果较常规方法治疗该病效果好。
Objective To investigate the clinical efficacy of meropenem in the treatment of neonatal intracranial hemorrhagic meningitis. Methods Ninety newborns with intracerebral hemorrhagic meningitis were randomly divided into two groups, 45 cases in each group. The control group was given ceftriaxone and other conventional treatment methods. The experimental group was given meropenem treatment on the basis of the control group, and the treatment effect and satisfaction of the family members were compared. Results The total effective rate was 91.11% in the experimental group, which was significantly higher than that in the control group (59.99%) (P <0.05). Family members of the experimental group were 89.66% satisfied with the treatment, which was significantly higher than that of the control group (62.07%) (P <0.05). Conclusion The clinical efficacy of meropenem in the treatment of neonatal intracranial hemorrhagic meningitis is better than that of conventional methods in the treatment of the disease.